Royal Bank of Canada
CRDF icon

Royal Bank of Canada’s Cardiff Oncology CRDF Stock Holding History

Royal Bank of Canada’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8K Buy
5,202
+3,477
+202% +$7.14K ﹤0.01% 6243
2025
Q4 		$4K Sell
1,725
-114,681
-99% -$266K ﹤0.01% 6753
2025
Q3 		$241K Sell
116,406
-75,140
-39% -$208K ﹤0.01% 4972
2025
Q2 		$603K Buy
191,546
+149,942
+360% +$457K ﹤0.01% 4318
2025
Q1 		$130K Sell
41,604
-24,282
-37% -$96K ﹤0.01% 5032
2024
Q4 		$286K Buy
65,886
+60,519
+1,128% +$189K ﹤0.01% 4519
2024
Q3 		$14K Sell
5,367
-15,703
-75% -$37.1K ﹤0.01% 6223
2024
Q2 		$47K Buy
21,070
+6,070
+40% +$22.9K ﹤0.01% 5683
2024
Q1 		$80K Buy
15,000
+14,534
+3,119% +$38.6K ﹤0.01% 5312
2023
Q4 		$0 Buy
466
+174
+60% +$210 ﹤0.01% 7183
2023
Q3 		$0 Sell
292
-19,007
-98% -$32.1K ﹤0.01% 7149
2023
Q2 		$28K Buy
19,299
+317
+2% +$511 ﹤0.01% 6035
2023
Q1 		$31K Sell
18,982
-4,000
-17% -$6.87K ﹤0.01% 5847
2022
Q4 		$32K Sell
22,982
-3,866
-14% -$5.54K ﹤0.01% 6102
2022
Q3 		$41K Sell
26,848
-18
-0.1% -$43 ﹤0.01% 5828
2022
Q2 		$60K Sell
26,866
-6,471
-19% -$10.8K ﹤0.01% 5630
2022
Q1 		$83K Sell
33,337
-15,735
-32% -$55.7K ﹤0.01% 5779
2021
Q4 		$295K Buy
49,072
+16,440
+50% +$98K ﹤0.01% 4952
2021
Q3 		$217K Buy
32,632
+18,957
+139% +$119K ﹤0.01% 5091
2021
Q2 		$90K Sell
13,675
-525
-4% -$4.45K ﹤0.01% 5677
2021
Q1 		$131K Buy
14,200
+5,081
+56% +$61.7K ﹤0.01% 5263
2020
Q4 		$164K Buy
9,119
+7,119
+356% +$125K ﹤0.01% 4998
2020
Q3 		$28K Buy
+2,000
New +$13.2K ﹤0.01% 5560
2019
Q2 		– Sell
-1
Closed – – 6907
2019
Q1 		$0 Buy
+1
New +$4 ﹤0.01% 6838
2018
Q4 		– Hold
0
– – – 6798
2018
Q3 		– Hold
0
– – – 6747
2018
Q2 		– Hold
0
– – – 6551
2018
Q1 		– Hold
0
– – – 6397
2017
Q4 		– Sell
-3
Closed -$133 – 6579
2017
Q3 		$0 Hold
3
– – ﹤0.01% 6739
2017
Q2 		$0 Sell
3
-37
-93% -$2.38K ﹤0.01% 6585
2017
Q1 		$3K Buy
40
+7
+21% +$951 ﹤0.01% 6338
2016
Q4 		$5K Buy
33
+22
+200% +$5.14K ﹤0.01% 6293
2016
Q3 		$4K Buy
11
+8
+267% +$2.92K ﹤0.01% 6015
2016
Q2 		$1K Sell
3
-3
-50% -$1.03K ﹤0.01% 6232
2016
Q1 		$2K Sell
6
-1
-14% -$340 ﹤0.01% 6118
2015
Q4 		$3K Sell
7
-18
-72% -$7.05K ﹤0.01% 6274
2015
Q3 		$10K Buy
25
+2
+9% +$1.05K ﹤0.01% 5874
2015
Q2 		$17K Sell
23
-35
-60% -$24.8K ﹤0.01% 5779
2015
Q1 		$29K Buy
+58
New +$24.7K ﹤0.01% 5191
2013
Q3 		– Sell
-1
Closed -$1K – 6104
2013
Q2 		$1K Buy
+1
New +$452 ﹤0.01% 5704

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Royal Bank of Canada's CRDF Position: Q1 2026 in Review

Royal Bank of Canada increased its Cardiff Oncology (CRDF) stake by 202% in Q1 2026, buying an estimated $7.14K and bringing the position to 5,202 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #6243.

Royal Bank of Canada first reported a position in CRDF in Q2 2013 and has held it in 36 quarters since. The position peaked at $603K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Royal Bank of Canada held 5,202 shares of Cardiff Oncology worth $8K as of Q1 2026.
  • Royal Bank of Canada bought 3,477 Cardiff Oncology shares in Q1 2026, an estimated $7.14K.
  • Cardiff Oncology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6243 holding.
  • Royal Bank of Canada first reported a position in Cardiff Oncology in Q2 2013 and has held it in 36 quarters since.
  • Royal Bank of Canada's Cardiff Oncology position peaked at $603K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.